Resources for Food and Drug Administration (FDA)

FDA Approves "Enbrel" For Pediatrics Suffering From Skin Psoriasis

www.topnews.in

The Food and Drug Administration approved the use of Enbrel for pediatric patients suffering from moderate to severe forms of skin psoriasis, after a panel of medical experts gave its nod to the drug.

From the FDA panel comprised of outside medical experts, the drug did not get a unanimous vote in its favor; seven voted in favor, five against while one abstained.

Enbrel is already an FDA approved treatment for adult and children’s rheumatoid arthritis, as well as adult psoriasis. The FDA panel expressed concerns about chances of the drug increasing malignancy and serious infections like tuberculosis. These were similar to concerns it raised regarding a proposed drug by Johnson & Johnson also for pediatric psoriasis, which got a unanimous approval from the panel.

View the Resource

Share or bookmarklet this web page at: